257 related articles for article (PubMed ID: 15966853)
1. CSF proteome: a protein repository for potential biomarker identification.
Romeo MJ; Espina V; Lowenthal M; Espina BH; Petricoin EF; Liotta LA
Expert Rev Proteomics; 2005 Jan; 2(1):57-70. PubMed ID: 15966853
[TBL] [Abstract][Full Text] [Related]
2. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
3. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
D'Ascenzo M; Relkin NR; Lee KH
Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
[TBL] [Abstract][Full Text] [Related]
7. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
Hsich G; Kenney K; Gibbs CJ; Lee KH; Harrington MG
N Engl J Med; 1996 Sep; 335(13):924-30. PubMed ID: 8782499
[TBL] [Abstract][Full Text] [Related]
8. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.
Burgess JA; Lescuyer P; Hainard A; Burkhard PR; Turck N; Michel P; Rossier JS; Reymond F; Hochstrasser DF; Sanchez JC
J Proteome Res; 2006 Jul; 5(7):1674-81. PubMed ID: 16823975
[TBL] [Abstract][Full Text] [Related]
9. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
10. Proteome analysis in the clinical chemistry laboratory: myth or reality?
Righetti PG; Castagna A; Antonucci F; Piubelli C; Cecconi D; Campostrini N; Rustichelli C; Antonioli P; Zanusso G; Monaco S; Lomas L; Boschetti E
Clin Chim Acta; 2005 Jul; 357(2):123-39. PubMed ID: 15970281
[TBL] [Abstract][Full Text] [Related]
11. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Harrington MG; Merril CR; Asher DM; Gajdusek DC
N Engl J Med; 1986 Jul; 315(5):279-83. PubMed ID: 3523251
[TBL] [Abstract][Full Text] [Related]
12. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
13. Mining ventricular cerebrospinal fluid from patients with traumatic brain injury using hexapeptide ligand libraries to search for trauma biomarkers.
Sjödin MO; Bergquist J; Wetterhall M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):2003-12. PubMed ID: 20542479
[TBL] [Abstract][Full Text] [Related]
14. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
15. CSF-studies in neuropsychiatric disorders.
Raedler TJ; Wiedemann K
Neuro Endocrinol Lett; 2006 Jun; 27(3):297-305. PubMed ID: 16807525
[TBL] [Abstract][Full Text] [Related]
16. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
Sinha A; Srivastava N; Singh S; Singh AK; Bhushan S; Shukla R; Singh MP
Clin Chim Acta; 2009 Feb; 400(1-2):14-20. PubMed ID: 18977210
[TBL] [Abstract][Full Text] [Related]
19. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
